ClinicalTrials.Veeva

Menu

Study of the Role of Top-down Processes in Neuronal Reorganization and Recovery From Sensory Loss: an Exploratory Behavioral and Electroencephalographic Study in Cochlear-supported Deaf Patients (REASCENT)

T

Toulouse University Hospital

Status

Not yet enrolling

Conditions

Deafness, Bilateral

Treatments

Behavioral: Cognitive, behavioral and quality of life assessment
Other: neurophysiological assessment

Study type

Observational

Funder types

Other

Identifiers

NCT07500909
RC31/26/0005
2026-A00163-48 (Other Identifier)

Details and patient eligibility

About

This study posits that central top-down processes (attention, inhibition), marked by alpha oscillations in EEG, play a key role. Understanding the evolution of these neuronal signatures and their link to pre-implantation visual dependence could allow the identification of biomarkers predictive of the success of auditory rehabilitation.

Full description

Profound bilateral deafness leads to sensory deprivation and neuronal reorganization ( visual recruitment of the auditory cortex). Although cochlear implants restore hearing, comprehension performance varies considerably. Peripheral factors explain only 40% of this variance. This study posits that central top-down processes (attention, inhibition), marked by alpha oscillations in EEG, play a key role. Understanding the evolution of these neuronal signatures and their link to pre-implantation visual dependence could allow the identification of biomarkers predictive of the success of auditory rehabilitation.

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

For cochlear implant patients:

  • Adult patients
  • Profound bilateral hearing loss requiring a first cochlear implant
  • Normal cochlear anatomy (confirmed by preoperative imaging)
  • Full insertion of the cochlear electrode array planned
  • Acceptance of the protocol and signing of the informed consent form
  • Enrollment in a social security or equivalent plan

For young patients with normal hearing:

  • Adult patients aged 18 to 40
  • Normal and symmetrical hearing
  • Acceptance of the protocol and signature of the informed consent form
  • Affiliation with a social security scheme or equivalent

For older patients with normal hearing:

  • Patients over 50 years of age, matched by gender and age (+/- 2 years) with the cochlear implant patient group
  • Normal and symmetrical hearing, with hearing thresholds < 20 dB HL at 2 kHz and < 40 dB HL at 4 kHz
  • Acceptance of the protocol and signature of the informed consent form
  • Affiliation with a social security scheme or equivalent

For experienced cochlear implant recipients:

  • Adult patients.
  • Unilateral cochlear implant activated for 1 year or more.
  • Disyllabic word recognition score at 60 dB in free field of 70% or higher.
  • Acceptance of the protocol and signature of the informed consent form.
  • Affiliation with a social security plan or equivalent.

For severely deaf patients fitted with hearing aids:

  • Adult patients.
  • Severe bilateral hearing loss.
  • Rehabilitation with one or two optimally fitted hearing aids.
  • Acceptance of the protocol and signing of the informed consent form.
  • Enrollment in a social security or equivalent health insurance plan.

Exclusion criteria

  • History of associated neurological pathology
  • Etiologies with unfavorable prognoses, such as recurrent chronic otitis media: These conditions are associated with a poor prognosis due to chronic inflammation that can affect the cochlea
  • Duration of profound bilateral deafness exceeding 5 years (worse prognosis)
  • Contraindications to EEG or other neurophysiological examinations within the study (for all groups)
  • Cognitive impairment confirmed by the MOCA test for the cochlear implant patient group and the group of elderly subjects with normal hearing
  • Use of psychotropic medications that may interfere with the results of cognitive or neurological tests
  • History of epilepsy or other major neurological disorders
  • Pregnancy or breastfeeding
  • Participation in another interventional research protocol or one that impacts the criteria studied in this project
  • Individuals under legal guardianship (guardianship, tutorship, curatorship, institutionalized, or under a future protection mandate)

Trial design

90 participants in 5 patient groups

Group of cochlear implant patients
Description:
This group consists of adult patients with profound bilateral hearing loss, candidates for a first unilateral cochlear implant, and meeting the specific inclusion criteria.
Treatment:
Other: neurophysiological assessment
Behavioral: Cognitive, behavioral and quality of life assessment
Group of young, normally hearing subjects
Description:
This control group consists of healthy young adult subjects (18-40 years old) with normal and symmetrical hearing confirmed by audiometry.
Treatment:
Other: neurophysiological assessment
Behavioral: Cognitive, behavioral and quality of life assessment
Group of normally hearing elderly subjects matched for gender and age
Description:
This control group consists of healthy older adults (\> 50 years) with age-appropriate hearing (thresholds defined in the inclusion criteria) confirmed by audiometry. They are matched by age (+/- 2 years) and gender with the cochlear implant patient group.
Treatment:
Other: neurophysiological assessment
Behavioral: Cognitive, behavioral and quality of life assessment
Group of experienced cochlear implant patients
Description:
This control group consists of adult patients using a unilateral cochlear implant for at least one year and exhibiting good hearing performance (≥70% word recognition).
Treatment:
Other: neurophysiological assessment
Behavioral: Cognitive, behavioral and quality of life assessment
Group of hearing-equipped deaf patients
Description:
This control group consists of adult patients with severe bilateral deafness who have been rehabilitated with optimally fitted hearing aids.
Treatment:
Other: neurophysiological assessment
Behavioral: Cognitive, behavioral and quality of life assessment

Trial contacts and locations

0

Loading...

Central trial contact

Mathieu MARX, Pr; Florine LEGAY

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems